Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Coronavirus Disease-2019 (COVID-19) Prevention”

25 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 25 results

Post-approval studies (Phase 4)Ended earlyNCT04346667
What this trial is testing

Post-Exposure Prophylaxis for Asymptomatic SARS-CoV-2 COVID-19 Patients With choloroquinE Compounds

Who this might be right for
SARS-CoV-2Coronavirus InfectionAsymptomatic Condition+1 more
Government of Punjab, Specialized Healthcare and Medical Education Department 125
Large-scale testing (Phase 3)Enrolling By InvitationNCT05787418
What this trial is testing

HH-120 Nasal Spray for Post-exposure Prevention of SARS-CoV-2

Who this might be right for
COVID-19
Huahui Health 1,200
Large-scale testing (Phase 3)Study completedNCT04353128
What this trial is testing

Efficacy of Melatonin in the Prophylaxis of Coronavirus Disease 2019 (COVID-19) Among Healthcare Workers.

Who this might be right for
Covid19SARS-CoV 2Coronavirus Infection
Instituto de Investigación Hospital Universitario La Paz 450
Not applicableStudy completedNCT04894409
What this trial is testing

Evaluation of Silver Nanoparticles for the Prevention of COVID-19

Who this might be right for
Coronavirus Disease 2019 (COVID-19)
Cluster de Bioeconomia de Baja California, A.C 231
Testing effectiveness (Phase 2)Ended earlyNCT05375760
What this trial is testing

A Randomized, Open-label, Dose-ranging Study in Adults and Pediatric Individuals ≥ 12 Years of Age to Assess the Safety, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of AZD7442, for Pre-exposure Prophylaxis of COVID-19

Who this might be right for
Coronavirus Disease 2019 (COVID-19)
AstraZeneca 251
Testing effectiveness (Phase 2)Study completedNCT04478071
What this trial is testing

Vadadustat for the Prevention and Treatment of Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19)

Who this might be right for
Acute Respiratory Distress SyndromeCoronavirus Infection
The University of Texas Health Science Center, Houston 448
Testing effectiveness (Phase 2)Ended earlyNCT04442230
What this trial is testing

NasoVAX in Patients With Early Coronavirus Infectious Disease 2019 (COVID-19)

Who this might be right for
Coronavirus Infection
Altimmune, Inc. 48
Large-scale testing (Phase 3)Study completedNCT04939428
What this trial is testing

Study of MK-4482 for Prevention of Coronavirus Disease 2019 (COVID-19) in Adults (MK-4482-013)

Who this might be right for
Coronavirus Disease (COVID-19)
Merck Sharp & Dohme LLC 2,441
Testing effectiveness (Phase 2)Study completedNCT04345653
What this trial is testing

Hydroxychloroquine as Chemoprevention for COVID-19 for High Risk Healthcare Workers

Who this might be right for
Covid19
Hackensack Meridian Health 48
Not applicableStudy completedNCT04927845
What this trial is testing

StriveWeekly Online Mental Health Trial Post-pandemic

Who this might be right for
AnxietyDepressive SymptomsStress, Emotional
Harvard University 538
Large-scale testing (Phase 3)UnknownNCT04437693
What this trial is testing

Post Exposure Prophylaxis in Healthcare Workers Exposed to COVID-19 Patients

Who this might be right for
COVID 19
Hamad Medical Corporation 500
Large-scale testing (Phase 3)UnknownNCT04320238
What this trial is testing

Experimental Trial of rhIFNα Nasal Drops to Prevent 2019-nCOV in Medical Staff

Who this might be right for
2019 Novel Coronavirus Infection
Shanghai Jiao Tong University School of Medicine 2,944
Early research (Phase 1)WithdrawnNCT04590274
What this trial is testing

Safety and Efficacy of Hydroxychloroquine for the Treatment & Prevention of Coronavirus Disease 2019 (COVID-19) Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Who this might be right for
Covid19SARS (Severe Acute Respiratory Syndrome)
International Brain Research Foundation
Testing effectiveness (Phase 2)Study completedNCT06234956
What this trial is testing

Open-label, Multi-centre, Non-Inferiority Study of Safety and Immunogenicity of BIMERVAX for the Prevention of COVID-19 in Adolescents From 12 Years to Less Than 18 Years of Age.

Who this might be right for
SARS CoV 2 Infection
Hipra Scientific, S.L.U 242
Testing effectiveness (Phase 2)Study completedNCT05007080
What this trial is testing

Evaluate Different Dose Levels of Ad26.COV2.S in Healthy Adolescents From 12 to 17 Years Inclusive

Who this might be right for
Coronavirus Disease-2019 (COVID-19) Prevention
Janssen Vaccines & Prevention B.V. 304
Not applicableUnknownNCT04438837
What this trial is testing

Hydroxychloroquine Post-Exposure Prophylaxis for Coronavirus Disease (COVID-19) Among Health-Care Workers

Who this might be right for
Coronavirus Disease 2019 (COVID-19)Post-Exposure Prophylaxis
Rambam Health Care Campus 582
Testing effectiveness (Phase 2)Ended earlyNCT05077969
What this trial is testing

Leidos-Enabled Adaptive Protocol (LEAP-CT) for Evaluation of Post-exposure Prophylaxis for Newly-infected COVID-19 Patients

Who this might be right for
2019 Novel Coronavirus Disease2019 Novel Coronavirus Infection2019-nCoV Disease+9 more
Leidos Life Sciences 4
Testing effectiveness (Phase 2)Study completedNCT04760730
What this trial is testing

Safety and Immunogenicity Study in Adults of AZD1222 and rAd26-S Administered as Heterologous Prime Boost Regimen for the Prevention of Coronavirus Disease 2019 (COVID-19)

Who this might be right for
COVID-19
R-Pharm 100
Testing effectiveness (Phase 2)Study completedNCT04409509
What this trial is testing

Treatment With CSL312 in Adults With Coronavirus Disease 2019 (COVID-19)

Who this might be right for
Coronavirus Disease 2019 (COVID-19)
CSL Behring 124
Not applicableStudy completedNCT05120869
What this trial is testing

Healthcare Provider Human Papillomavirus Education and Professional Skills Intervention

Who this might be right for
Health Personnel AttitudeHealth Knowledge, Attitudes, Practice
University of Texas, El Paso 161
Next Page